Blockade of adenosine A 2B receptors ameliorates murine colitis

V. L. Kolachala, B. K. Ruble, M. Vijay-Kumar, L. Wang, S. Mwangi, H. E. Figler, R. A. Figler, S. Srinivasan, A. T. Gewirtz, J. Linden, D. Merlin, S. V. Sitaraman

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Abstract

Background and purpose: The adenosine 2B (A 2B) receptor is the predominant adenosine receptor expressed in the colon. Acting through the A 2B receptor, adenosine mediates chloride secretion, as well as fibronectin and interleukin (IL)-6 synthesis and secretion in intestinal epithelial cells. A 2B receptor mRNA and protein expression are increased during human and murine colitis. However, the effect of the A 2B receptor in the activation of the intestinal inflammatory response is not known. In this study, we examined the effect of A 2B receptor antagonism on murine colitis. Experimental approach: Dextran sodium sulphate (DSS)-treated mice and piroxicam-treated IL-10 -/- mice were used as animal models of colitis. The A 2B receptor-selective antagonist, ATL-801, was given in the diet. Key results: Mice fed ATL-801 along with DSS showed a significantly lower extent and severity of colitis than mice treated with DSS alone, as shown by reduced clinical symptoms, histological scores, IL-6 levels and proliferation indices. The administration of ATL-801 prevented weight loss, suppressed the inflammatory infiltrate into colonic mucosa and decreased epithelial hyperplasia in piroxicam-treated IL-10 -/- mice. IL-6 and keratinocyte-derived chemokine (KC) concentrations in the supernatants of colonic organ cultures from colitic mice were significantly reduced by ATL-801 administration. Conclusions and implications: Taken together, these data demonstrate that the intestinal epithelial A 2B receptor is an important mediator of pro-inflammatory responses in the intestine and that A 2B receptor blockade may be an effective therapeutic strategy to treat inflammatory bowel disease.

Original languageEnglish (US)
Pages (from-to)127-137
Number of pages11
JournalBritish Journal of Pharmacology
Volume155
Issue number1
DOIs
StatePublished - Sep 2008

All Science Journal Classification (ASJC) codes

  • Pharmacology

Fingerprint Dive into the research topics of 'Blockade of adenosine A <sub>2B</sub> receptors ameliorates murine colitis'. Together they form a unique fingerprint.

Cite this